Cholera toxin as a model AB5 toxin: functional significance of B-subunit pentamerization in GM1 recognition, pathogenicity, and delivery efficiency
Archives of Toxicology · 2026-08 · 100 (8) · 3279-3292
DOI: 10.1007/s00204-026-04455-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Toxicology, online erschienen am 20.05.2026. Verfasst von Yeo-Jin Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chosun University, Gwangju, South Korea. Hauptthemen laut MEDLINE: Cholera Toxin, G(M1) Ganglioside. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Optical Society of Korea.
Abstract (Originalsprache)
AB5 toxins constitute a major family of bacterial exotoxins. Their pathogenicity depends on the coordinated actions of two components: an enzymatically active A subunit and a pentameric B subunit. The B subunit mediates host cell recognition and intracellular trafficking. Among them, cholera toxin represents a representative model for investigating structure-function relationships governing toxin entry and delivery. While the catalytic activity of the A subunit has been extensively characterized, growing evidence indicates that pathogenic outcomes are critically shaped by trafficking strategies encoded within the B subunit pentamer. This review focuses on the cholera toxin B subunit (CTB) as a model system to elucidate how pentameric organization enables multivalent GM1 recognition, receptor clustering, and efficient intracellular transport. We summarize current knowledge on the molecular basis of CTB pentamerization, its thermodynamic and structural advantages, and the role of multivalency in amplifying delivery efficiency and pathogenicity. In addition, we examine how CTB-mediated intracellular trafficking influences uptake pathway selection and intracellular routing, thereby contributing to consistent and robust toxic outcomes. Beyond pathogenic mechanisms, we briefly discuss the potential implications of CTB-mediated trafficking for translational applications. By integrating structural, cellular, and functional perspectives, this review demonstrates how CTB-mediated mobility governs intracellular routing and uptake pathway selection. This framework provides a basis for understanding AB5 toxin pathogenicity and its broader biological significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Chosun University, Gwangju, South Korea.
- Environmental Diseases Research Center, Korea Research, Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, South Korea.
- Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.
- College of Pharmacy, Chosun University, Gwangju, South Korea. kcy12@chosun.ac.kr.
- College of Pharmacy, Research Institute of Pharmaceutical Sciences (RIPS), Chosun University, Dong-gu, Gwangju, 61452, Republic of Korea. kcy12@chosun.ac.kr.
ORCID-Profile: Chang-Ung Kim
Förderung
- Optical Society of Korea
Zitieren
APA
Park, Y. J., Lee, K. S., Lim, D., & Kim, C. U. (2026). Cholera toxin as a model AB5 toxin: functional significance of B-subunit pentamerization in GM1 recognition, pathogenicity, and delivery efficiency. Archives of Toxicology, 100(8), 3279-3292. https://doi.org/10.1007/s00204-026-04455-3
Vancouver
Park YJ, Lee KS, Lim D, Kim CU. Cholera toxin as a model AB5 toxin: functional significance of B-subunit pentamerization in GM1 recognition, pathogenicity, and delivery efficiency. Archives of Toxicology. 2026;100(8):3279-3292. doi:10.1007/s00204-026-04455-3
BibTeX
@article{Park2026,
author = {Park, Yeo-Jin and Lee, Kyung-Soo and Lim, Dahwan and Kim, Chang-Ung},
title = {Cholera toxin as a model AB5 toxin: functional significance of B-subunit pentamerization in GM1 recognition, pathogenicity, and delivery efficiency},
journal = {Archives of Toxicology},
year = {2026},
volume = {100},
number = {8},
pages = {3279--3292},
doi = {10.1007/s00204-026-04455-3}
}
EUVIMED